The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, P. R. China.
Small. 2019 Oct;15(42):e1902636. doi: 10.1002/smll.201902636. Epub 2019 Aug 29.
Although photothermal therapy (PTT) is preclinically applied in solid tumor treatment, incomplete tumor removal of PTT and heat endurance of tumor cells induces significant tumor relapse after treatment, therefore lowering the therapeutic efficiency of PTT. Herein, a programmable therapeutic strategy that integrates photothermal therapeutic agents (PTAs), DNAzymes, and artificial engineered natural killer (A-NK) cells for immunotherapy of hepatocellular carcinoma (HCC) is designed. The novel PTAs, termed as Mn-CONASHs, with 2D structure are synthesized by the coordination of tetrahydroxyanthraquinone and Mn ions. By further adsorbing polyetherimide/DNAzymes on the surface, the DNAzymes@Mn-CONASHs exhibit excellent light-to-heat conversion ability, tumor microenvironment enhanced T -MRI guiding ability, and antiheat endurance ability. Furthermore, the artificial engineered NK cells with HCC specific targeting TLS11a-aptamer decoration are constructed for specifically eliminating any possible residual tumor cells after PTT, to systematically enhance the therapeutic efficacy of PTT and avoid tumor relapse. Taken together, the potential of A-NK cells combined with antiheat endurance as a powerful strategy for immuno-enhancing photothermal therapy efficiency of solid tumors is highlighted, and the current strategy might provide promising prospects for cancer therapy.
尽管光热疗法(PTT)在实体肿瘤治疗中已得到临床应用,但 PTT 不完全清除肿瘤和肿瘤细胞的耐热性导致治疗后肿瘤明显复发,从而降低了 PTT 的治疗效果。在此,设计了一种可编程的治疗策略,该策略将光热治疗剂(PTAs)、DNA 酶和人工工程自然杀伤(A-NK)细胞整合在一起,用于肝癌(HCC)的免疫治疗。新型 PTA 称为 Mn-CONASHs,具有二维结构,由四羟基蒽醌和 Mn 离子配位合成。通过进一步在表面吸附聚醚酰亚胺/DNA 酶,DNA 酶@Mn-CONASHs 表现出优异的光热转换能力、肿瘤微环境增强的 T-MRI 引导能力和抗耐热性。此外,构建了具有 HCC 特异性靶向 TLS11a-适体修饰的人工工程 NK 细胞,用于特异性消除 PTT 后任何可能的残留肿瘤细胞,从而系统地增强 PTT 的治疗效果并避免肿瘤复发。总之,强调了 A-NK 细胞与耐热性相结合作为增强实体瘤免疫光热治疗效率的强大策略的潜力,并且该策略可能为癌症治疗提供有前景的前景。